From AI
Hospitals do not make money directly from blood donations themselves—blood is donated voluntarily and for free in the US (regulated by the FDA and organizations like the American Red Cross).
However, hospitals and blood centers do charge fees to cover the costs of processing, testing, storing, and distributing blood. Here’s how the money flows:
- Blood is Donated for Free (Whole Blood)
In the US, whole blood donation is 100% voluntary and unpaid through nonprofits like the American Red Cross (which supplies ~45% of the nation’s blood) or community blood centers (another ~50%).
- Hospitals Pay Blood Centers for “Blood Products”
Even though the blood is free, hospitals must pay for:
- Collection & transportation
- Screening for diseases (HIV, hepatitis, syphilis, etc.—up to 30 tests per unit)
- Blood typing & cross-matching
- Separation into components (red cells, plasma, platelets)
- Storage (refrigeration, freezing)
- Quality control & safety testing
- Administrative & logistical costs
These fees are negotiated between hospitals and suppliers (e.g., Red Cross) and cover ~98–100% of costs, with slim margins (e.g., 3% for some centers).
- Hospitals Bill Patients or Insurers
Hospitals mark up the blood product cost plus their own handling, transfusion administration, and staff fees.
Public/nonprofit hospitals get reimbursed via Medicare/Medicaid (e.g., Medicare covers after first 3 units/year or donor replacement; deductible : $1,676 in 2025 for inpatient).
Private hospitals bill insurance or patients directly—transfusions can cost $1,000–$5,000+ per unit to the end user.
The overall blood market was valued at $11.5 billion in 2023, driven by these fees.
- Plasma: The Big Money-Maker (Separate System)
Whole blood plasma is a byproduct for transfusions (low revenue), but source plasma for drugs is a massive industry:
Collected via paid apheresis at for-profit centers (e.g., CSL Plasma, Grifols), donors get $30–$100 per donation (up to 2x/week), totaling $400–$800/month.
US supplies 70% of global plasma; centers sell to pharma companies for fractionation into meds (e.g., immunoglobulins, clotting factors).
Revenue: $20–$25 billion globally (2023), with US centers earning billions—e.g., Red Cross biomedical services brought in $1.8B (2022), subsidizing free blood ops.
This is not from transfusion donations; paid plasma is labeled “paid donor” and used only for manufacturing, not direct transfusions.
Summary: Where Hospitals “Make Money”
Source
Revenue for Hospital?
Blood donation itself
No
Fees charged to patients/insurers for transfusion services
Yes (markup on processing/admin)
Reimbursement from Medicare/insurance
Yes
Plasma sold to pharma (from paid donors)
No (handled by separate for-profit centers)